Hedge funds are rapidly reducing their exposure to global information technology stocks, with the latest sell-off marking the fastest decline in six months. Most sales are reported to be in ...

Generative AI is a rapidly evolving technology and HBS’ policies may be updated from time to time. Students are expected to remain informed. Faculty may allow the use of ChatGPT and similar ...

Known as Zynteglo in Europe where it is approved to treat the rare blood disorder beta-thalassemia, the gene therapy has been given the all-clear by bluebird’s scientists after reviewing the ...

Our doctoral students represent diverse backgrounds, degrees, undergraduate schools, and disciplines. Some students enter our doctoral programs upon graduation from college, while others spend a few ...

In addition to the cell therapy programmes, for example, it is also working with CRISPR Therapeutics on CTX001, a gene-editing therapy for beta thalassemia and sickle cell disease. “We have ...